CSIMarket
 
Ars Pharmaceuticals Inc   (NASDAQ: SPRY)
 

Ars Pharmaceuticals Inc's Suppliers Performance

SPRY's Supply Chain




 
SPRY Costs vs Sales of Suppliers Growth

More on SPRY Suppliers






Ars Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials, drug substances, and drug products for preclinical research, clinical trials, and commercial supply from third-party suppliers and manufacturers. Epinephrine, the active pharmaceutical ingredient in Neffy, is obtained from Cambrex Profarmco, which holds a U.S. drug master file for epinephrine produced in Italy and maintains a commercial supply agreement with the company. Dodecyl maltoside (Intravail) is acquired under a license agreement with Aegis Therapeutics, LLC from two manufacturers: Dr. Reddy Laboratories in India and Inalco in Italy. The unit dose sprayer device for Neffy is manufactured by Aptar Pharma in France and the U.S., and by Silgan Dispensing Systems in Germany, both with sufficient production capacity. Drug product manufacturing and final packaging are performed by Renaissance Lakewood, LLC at its Lakewood, New Jersey facility under a commercial supply agreement. The company oversees contract manufacturing organizations internally and with third-party consultants. Stability studies indicate that Neffy remains stable at room temperature for up to 30 months.

Ars Pharmaceuticals Inc's Comment on Supply Chain


The company sources raw materials, drug substances, and drug products for preclinical research, clinical trials, and commercial supply from third-party suppliers and manufacturers. Epinephrine, the active pharmaceutical ingredient in Neffy, is obtained from Cambrex Profarmco, which holds a U.S. drug master file for epinephrine produced in Italy and maintains a commercial supply agreement with the company. Dodecyl maltoside (Intravail) is acquired under a license agreement with Aegis Therapeutics, LLC from two manufacturers: Dr. Reddy Laboratories in India and Inalco in Italy. The unit dose sprayer device for Neffy is manufactured by Aptar Pharma in France and the U.S., and by Silgan Dispensing Systems in Germany, both with sufficient production capacity. Drug product manufacturing and final packaging are performed by Renaissance Lakewood, LLC at its Lakewood, New Jersey facility under a commercial supply agreement. The company oversees contract manufacturing organizations internally and with third-party consultants. Stability studies indicate that Neffy remains stable at room temperature for up to 30 months.







SPRY's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Ars Pharmaceuticals Inc 408.17 116.93 -215.43 163
SUBTOTAL 0.00 0.00 0.00 -


Sources: Ars Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Ars Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.